Your Location:
Home >
Browse articles >
Fangji Fulingtang Attenuates Myocardial Fibrosis by Regulating Mitochondrial Function Through AMPK/PGC-1α /MFN2-PKM2 Signaling Pathway
Fangji Fulingtang Attenuates Myocardial Fibrosis by Regulating Mitochondrial Function Through AMPK/PGC-1
α /MFN2-PKM2 Signaling Pathway- Chinese Journal of Experimental Traditional Medical Formulae Pages: 1-10(2026)
DOI: 10.13422/j.cnki.syfjx.20260442
Revised:2026-02-27 ,
Accepted:04 March 2026
Scan QR Code
Full Text(HTML)
Figs( 6 ) Tabs( 7 )
References
Publication Info
Metrics
6
Views
5
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Molecular Mechanism Analysis of Dengzhan Shengmai Capsules Against Myocardial Fibrosis After Myocardial Infarction Based on Network Robustness Algorithm
Danggui Shaoyaosan Alleviates Cognitive Impairment by Regulating Ketone Body Metabolism and Glutamate/AMPAR Pathway
Current Status and Evaluation Considerations of Constructing Disease-syndrome Combination Models for Spleen Deficiency with Dampness Pattern in Ulcerative Colitis
Danlianxin Formula Ameliorates Cardiac Dysfunction Associated with Myocardial Infarction in Hyperlipidemic Rats via Epac1/VDAC1/NLRP3/Caspase Signaling Pathway
Mechanism of Action of Shengmai San-type Formulas in Treatment of Chronic Heart Failure Based on Yin-Yang Theory
Related Author
OU Feifei
ZHANG Bo
PAN Fuzhu
WEI Junying
WU Hongwei
XIAN Minghua
XU Jing
WANG Shasha
Related Institution
School of Traditional Chinese Medicine(TCM), Guangdong Pharmaceutical University
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Institute of TCM Health Industry,China Academy of Chinese Medical Sciences
School of Pharmacy, Zunyi Medical University
Panzhou TCM Hospital


